|
|
Volumn 9, Issue 3, 2002, Pages 568-572
|
|
Predicting Kala-Azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN G ANTIBODY;
K39 ANTIBODY;
RECOMBINANT ANTIGEN;
RECOMBINANT K39 ANTIGEN;
UNCLASSIFIED DRUG;
ACCURACY;
ANTIBODY DETECTION;
ANTIBODY TITER;
ANTIGEN BINDING;
ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
EARLY DIAGNOSIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ERADICATION THERAPY;
FAMILY HISTORY;
FOLLOW UP;
HUMAN;
INFECTION;
LEISHMANIA DONOVANI;
LEISHMANIASIS;
MAJOR CLINICAL STUDY;
MASS SCREENING;
PREDICTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RELIABILITY;
SENSITIVITY ANALYSIS;
SERODIAGNOSIS;
SKIN DISEASE;
SYMPTOM;
WOUND HEALING;
ANIMALS;
ANTIBODIES, PROTOZOAN;
ANTIGENS, PROTOZOAN;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HUMANS;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
LEISHMANIA DONOVANI;
LEISHMANIASIS, VISCERAL;
PREDICTIVE VALUE OF TESTS;
PROTOZOAN PROTEINS;
RECOMBINANT PROTEINS;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0036100331
PISSN: 1071412X
EISSN: None
Source Type: Journal
DOI: 10.1128/CDLI.9.3.568-572.2002 Document Type: Article |
|
Times cited : (94)
|
|
References (16)
|
